Q&A with Erica Jonlin PhD, Author of Perspective on Informed Consent Published in Stem Cell Reports

April 14, 2020 | Categories: Administrative Staff | Tagged: , ,

Background In November 2018, Dr. He Jiankui used a series of YouTube videos to announce the birth of the world’s first genetically-modified babies, twin girls who soon became known as the CRISPR babies. In a stunning, unapologetic presentation to the international scientific research community, Dr. He reported that he had edited a specific gene in […] Read More

Erica Jonlin is regulatory manager for several planned gene-transfer and stem-cell clinical trials to be conducted in the University of Washington School of Medicine.

Differing U.S. standards stymie stem-cell research

February 6, 2014 | Categories: Announcements | Tagged: , , ,

NIH, FDA policies appear to make most federally funded embryonic stem cell lines unsuitable for clinical use Since the discovery of human embryonic stem cells, scientists have had high hopes for their use to treat a wide variety of diseases. In 2009 the National Institutes of Health established funding guidelines for research that dictate that […] Read More